Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
about
Human and great ape red blood cells differ in plasmalogen levels and compositionInvestigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study.Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation.Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP MiceThe Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome.Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response PhenotypesReview article: Biomarkers of clinical outcomes in advanced chronic kidney disease.Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state.Cardiovascular risk in the peritoneal dialysis patient.Advances in methods for the determination of biologically relevant lipid peroxidation products.What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients.Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients.Oxidative environment causes molecular remodeling in embryonic heart-a metabolomic and lipidomic fingerprinting analysis.Dimethyl acetals, an indirect marker of the endogenous antioxidant plasmalogen level, are reduced in blood lipids of Sudanese pre-eclamptic subjects whose background diet is high in carbohydrate.Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?Characterizing the Key Metabolic Pathways of the Neonatal Mouse Heart Using a Quantitative Combinatorial Omics Approach.
P2860
Q21245699-FCECDD68-F312-4922-9F8C-13AEC7691D4BQ30245541-399FCC34-3E90-4EDB-8443-C4E76430CE7AQ33986680-0099B821-FA2E-4BDA-B8A9-4CE378F8EC1BQ35143143-0C046E39-D34A-4766-BB42-F4DD25D62725Q35951218-F8E7275D-EEA7-41D4-B668-3DF28400B25DQ36209750-A5A573CB-971C-400D-BCB0-1B3D29FBC93CQ36473120-881E0F04-CE2E-4877-9885-1BB78477DDDAQ37534821-F7CFD683-492A-4048-8C1A-72BC964D554EQ37604744-C4DAD859-A709-4E66-8698-FF9988D09380Q37716377-EB7A3F12-4A4C-4A07-A10E-F2F1FAA5835FQ37766750-47138F0A-5A53-40C6-AAE9-177EF544EC3BQ37788232-FCD8AA97-68DD-41C4-B8F8-6C08DB0F7041Q37837005-B67D4C76-144D-43ED-9AA3-632923B29A4BQ38786018-3B2F0885-CCA8-42F6-970B-EAE25C4B4CCFQ44916889-71FD1A25-2354-4A2C-81B2-684DA286B4D9Q46093171-7A7D1D5B-FC0B-4030-9730-91B40D7A43A5Q46312759-DC59D8A2-D7C6-4A36-AD7D-DC56B83A02CCQ46725519-7A9FCE98-7A5A-4778-8866-1AF0032761CCQ47732797-36E16A38-BFA7-4EC7-BCD9-DC0BE1694DF4Q52562672-6CA94D56-8DAA-426A-98DF-2C183B08C16F
P2860
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@en
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@nl
type
label
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@en
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@nl
prefLabel
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@en
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@nl
P2860
P50
P356
P1476
Phospholipid plasmalogen, a su ...... on renal replacement therapy.
@en
P2860
P304
P356
10.1093/NDT/GFH035
P407
P577
2004-04-01T00:00:00Z